We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Patients prefer patient organizations over pharma companies when it comes to services. While that may not be surprising on its own, it is evidence of an increasing trend of patient reliance on organizations for emotional, financial and even educational su
Novo Nordisk has purchased Berkeley LightsBeacon Optofluidic platform to accelerate workflows in cell line development and to use the platform for future protein and antibody discovery.